{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:43Z","timestamp":1786649743487,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"abstract":"\n Background:<\/jats:title>\n It has been established that sublingual (SL) route of misoprostol has a great potential to be developed for medical abortion, but there is dearth of evidence to reveal satisfaction rate and safety profile among patients of oral and SL routes. Thus, this study was conducted to provide an insight into the acceptability and safety profile of the same.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n A randomized controlled trial was carried out by giving 200 mg mifepristone orally, followed by administration of 600\n \u03bc<\/jats:italic>\n g misoprostol orally to 50 women and sublingually to 50 women. The primary endpoints of study were measurements of acceptability and safety profile parameters (average blood loss, nausea, vomiting, diarrhea, hot flushes, fever) of both the groups. The secondary endpoints of the study were number of doses required for complete abortion, success rate and the induction to evacuation interval in both the groups.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n SL route of administration was more acceptable than the oral route (\n P<\/jats:italic>\n = 0.009). Average blood loss was higher in the oral group than in the SL group (\n P<\/jats:italic>\n = 0.001). Amongst the side effects, 34% in the SL group and 52% in the oral group had nausea (\n P<\/jats:italic>\n = 0.264), 22% in the SL group and 44% in the oral group had vomiting (\n P<\/jats:italic>\n = 0.031), 48% in the SL group and 86% in the oral group had diarrhea (\n P<\/jats:italic>\n < 0.05), hot flushes were presented by 24% in the SL group and 50% in the oral group (\n P<\/jats:italic>\n < 0.05), fever was presented by 20% in the SL group and 44% in the oral group (\n P<\/jats:italic>\n < 0.05), and the number of cases aborted with only one dose was higher (86%) in the SL group as compared to 63% in the oral group (\n P<\/jats:italic>\n = 0.004). The evacuation (success) rates were 92% in the SL group and 84% in the oral group (\n P<\/jats:italic>\n = 0.218) and the mean \u00b1 SD induction to evacuation intervals in the SL and oral groups were 5.6 \u00b1 4.54 hours and 9.44 \u00b1 5.61 hours, respectively (\n P<\/jats:italic>\n = 0.0002).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n The SL route had fewer undesirable effects, was more satisfactory, required less number of doses and was more acceptable to the patient compared to the oral route.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0253-7613.81513","type":"journal-article","created":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T10:05:28Z","timestamp":1306577128000},"page":"306-310","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise"],"prefix":"10.4103","volume":"43","author":[{"given":"Devendra Singh","family":"Kushwah","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Era's Lucknow Medical College and Hospital, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Kushwah","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Lady Harding Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Tariq","family":"Salman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Era's Lucknow Medical College and Hospital, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. K.","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Era's Lucknow Medical College and Hospital, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijgo.2004.04.038","article-title":"Management of early pregnancy loss","volume":"86","author":"Graziosi","year":"2004","journal-title":"Int J Gynecol Obstet"},{"key":"R2-20260605","first-page":"248","article-title":"A medical approach to management of spontaneous abortion using misoprostol","volume":"76","author":"Chung","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"El-Refacy","year":"1995","journal-title":"N Eng J Med"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misopristol compared with oral misopristol in termination of second trimester pregnancy","volume":"90","author":"Ho","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misopristol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0010-7824(99)00032-3","article-title":"Early abortion with 800 \u00ccg of misopristol by vaginal route","volume":"59","author":"Carbonell","year":"1999","journal-title":"Contraception"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misopristol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/humrep\/17.3.654","article-title":"Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/humrep\/deh005","article-title":"Effects of misoprostol on uterine contractility following different routes of administration","volume":"19","author":"Aronsson","year":"2004","journal-title":"Hum Reprod"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: Drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-0528.2002.01075.x","article-title":"Medical management of early fetal demise using sublingual Misoprostol","volume":"109","author":"Waggarachchi","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/humrep\/deg013","article-title":"A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1471-0528.2002.01459.x","article-title":"Sublingual compared with oral misoprostol in term labour induction: A randomised controlled trial","volume":"109","author":"Shetty","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humrep\/deh001","article-title":"Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions","volume":"19","author":"Saxena","year":"2004","journal-title":"Hum Reprod"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/humrep\/13.10.2962","article-title":"An effective regimen for early medical abortion: A report of 2000 consecutive cases","volume":"13","author":"Ashok","year":"1998","journal-title":"Hum Reprod"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low does Mifepristone followed by vaginal misoprostol at 48 hours for abortion upto 63 days","volume":"61","author":"Schaff","year":"2000","journal-title":"Contraceptions"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363791-201143030-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:53Z","timestamp":1786647473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363791-201143030-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0253-7613.81513","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"2010-09-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}